ACE and stroke disorder: The first article concerned a treatment of diabetic gastroparesis, the second was a cost analysis of kinetic therapy in preventing complications of stroke, the third was a randomized trial of surgery as a treatment for metastases to the brain, and the fourth examined nephrotoxicity following treatment with angiotensin-converting enzyme (ACE) inhibitors and nonsteroidal anti-inflammatory drug (NSAID) therapy [29].